December 22, 2025 AlertsNew BIOSECURE Act Targets Foreign-Linked BiotechBy Jianming Jimmy Hao, Ph.D., Joe Chen, Ph.D., Jonathan R. Lagarenne and Gerard P. Norton, Ph.D.
June 26, 2025 ArticlesHow to Navigate the Biosimilar and Biologic Markets Amid Challenging US Litigation TrendsIntellectual Asset ManagementBy Gerard P. Norton, Jonathan R. Lagarenne, Jianming Jimmy Hao, Howard S. Suh and Jonathan J. Madara
August 25, 2023 ArticlesBiosimilars and Biologics Litigation in the United StatesIAMBy Gerard P. Norton, Ph.D., Jonathan R. Lagarenne, Jianming Jimmy Hao, Ph.D., Howard S. Suh and Jonathan J. Madara
April 04, 2022 ArticlesThe Tin Man Needs a Heart: A Proposed Framework for the Regulation of Bioprinted OrgansFordham Law ReviewBy Linda Foit, Ph.D.
August 10, 2020 AlertsUSPTO Launches Patent Licensing Platform to Promote COVID-19 Technology DevelopmentBy Michael W. Glynn, Ph.D.
July 02, 2020 AlertsUSPTO Launches COVID-19 Prioritized Patent Application Examination PilotBy James M. Singer
June 05, 2020 ArticlesPandemic Poses Peril for Both Sides in IP LicensesThomson Reuters WestlawBy Melissa E. Scott
March 24, 2020 AlertsTo Speed COVID-19 Testing, FDA Eases Rules, Opens Options for Labs and ManufacturersBy Margaret J. Davino
July 31, 2019 ArticlesDrp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor GrowthCell ReportsBy Nagdas S., Kashatus, J.A., Nascimento, A., Hussain, S.S., Trainor, R.E., Pollock, S.R., Adair, S.J., Michaels, A.D., Sesaki, H., Stelow, E.B., Bauer, T.W. and Kashatus D.F.
April 17, 2019 ArticlesRalA and RalB Relocalization to Depolarized Mitochondria Depends on Clathrin-Mediated Endocytosis and Facilitates TBK1 ActivationPLOS ONEBy Pollock S.R., Schinlever A.R., Rohani, A., Kashatus J.A. and Kashatus, D.F.
June 01, 2018 ArticlesRalEncyclopedia of Signaling MoleculesBy Sarah R. Pollock and David F. Kashatus
January 08, 2016 ArticlesThe Trans-Pacific Partnership Patent Provisions’ Impact on the U.S. Pharmaceutical IndustryBloomberg BNABy Gerard P. Norton, Ph.D.